Pebblebrook Hotel Trust has a consensus price target of $24.32 based on the ratings of 14 analysts. The high is $125 issued by Barclays on July 5, 2023. The low is $11 issued by Morgan Stanley on November 7, 2023. The 3 most-recent analyst ratings were released by Wells Fargo, Truist Securities, and Wells Fargo on February 18, 2025, February 4, 2025, and December 9, 2024, respectively. With an average price target of $14 between Wells Fargo, Truist Securities, and Wells Fargo, there's an implied 75.88% upside for Pebblebrook Hotel Trust from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/10/2025 | Buy Now | — | Compass Point | Floris Van Dijkum58% | — | Downgrade | Buy → Neutral | Get Alert |
02/18/2025 | Buy Now | 63.32% | Wells Fargo | Dori Kesten57% | $16 → $13 | Maintains | Equal-Weight | Get Alert |
02/04/2025 | Buy Now | 63.32% | Truist Securities | Gregory Miller66% | $14 → $13 | Maintains | Hold | Get Alert |
12/09/2024 | Buy Now | 101.01% | Wells Fargo | Dori Kesten57% | $14 → $16 | Maintains | Equal-Weight | Get Alert |
11/26/2024 | Buy Now | 75.88% | Wells Fargo | Dori Kesten57% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
11/22/2024 | Buy Now | 88.44% | Stifel | Simon Yarmak54% | $14.75 → $15 | Upgrade | Hold → Buy | Get Alert |
11/21/2024 | Buy Now | 113.57% | Compass Point | Floris Van Dijkum58% | $17 → $17 | Upgrade | Neutral → Buy | Get Alert |
11/08/2024 | Buy Now | 79.02% | Stifel | Simon Yarmak54% | $14.75 → $14.25 | Maintains | Hold | Get Alert |
11/04/2024 | Buy Now | 79.02% | Stifel | Simon Yarmak54% | $16 → $14.25 | Maintains | Hold | Get Alert |
10/31/2024 | Buy Now | 75.88% | Baird | Michael Bellisario56% | $15 → $14 | Maintains | Neutral | Get Alert |
10/28/2024 | Buy Now | 75.88% | Truist Securities | Gregory Miller66% | $15 → $14 | Maintains | Hold | Get Alert |
09/13/2024 | Buy Now | 63.32% | Wells Fargo | Dori Kesten57% | $15 → $13 | Maintains | Equal-Weight | Get Alert |
05/30/2024 | Buy Now | 88.44% | Truist Securities | Gregory Miller66% | $16 → $15 | Maintains | Hold | Get Alert |
03/28/2024 | Buy Now | 113.57% | Compass Point | Floris Van Dijkum58% | $28 → $17 | Downgrade | Buy → Neutral | Get Alert |
02/22/2024 | Buy Now | 119.85% | Stifel | Simon Yarmak54% | $16.5 → $17.5 | Maintains | Hold | Get Alert |
01/18/2024 | Buy Now | 101.01% | Truist Securities | Gregory Miller66% | $15 → $16 | Maintains | Hold | Get Alert |
01/12/2024 | Buy Now | 88.44% | Baird | Michael Bellisario56% | $14 → $15 | Maintains | Neutral | Get Alert |
01/08/2024 | Buy Now | 69.6% | B of A Securities | Shaun Kelley57% | → $13.5 | Downgrade | Neutral → Underperform | Get Alert |
12/22/2023 | Buy Now | 101.01% | Wells Fargo | Dori Kesten57% | $14 → $16 | Maintains | Equal-Weight | Get Alert |
12/08/2023 | Buy Now | 75.88% | Wells Fargo | Dori Kesten57% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
11/13/2023 | Buy Now | 63.32% | Wells Fargo | Dori Kesten57% | $16 → $13 | Maintains | Equal-Weight | Get Alert |
11/07/2023 | Buy Now | 38.19% | Morgan Stanley | Stephen Grambling61% | $12 → $11 | Maintains | Underweight | Get Alert |
10/30/2023 | Buy Now | 75.88% | Baird | Michael Bellisario56% | $16 → $14 | Maintains | Neutral | Get Alert |
10/19/2023 | Buy Now | 88.44% | Truist Securities | Gregory Miller66% | $16 → $15 | Maintains | Hold | Get Alert |
10/16/2023 | Buy Now | 50.75% | Morgan Stanley | Stephen Grambling61% | $11 → $12 | Maintains | Underweight | Get Alert |
10/03/2023 | Buy Now | 75.88% | Wedbush | Richard Anderson66% | → $14 | Initiates | → Neutral | Get Alert |
09/28/2023 | Buy Now | — | Wolfe Research | Keegan Carl64% | — | Initiates | → Peer Perform | Get Alert |
09/22/2023 | Buy Now | 101.01% | Truist Securities | Gregory Miller66% | $16 → $16 | Reiterates | Hold → Hold | Get Alert |
08/25/2023 | Buy Now | 38.19% | Morgan Stanley | Stephen Grambling61% | $12 → $11 | Maintains | Underweight | Get Alert |
07/31/2023 | Buy Now | 101.01% | Wells Fargo | Dori Kesten57% | $15 → $16 | Maintains | Equal-Weight | Get Alert |
07/31/2023 | Buy Now | 101.01% | Baird | Michael Bellisario56% | $14 → $16 | Maintains | Neutral | Get Alert |
07/14/2023 | Buy Now | 88.44% | Citigroup | Smedes Rose38% | $16.5 → $15 | Maintains | Neutral | Get Alert |
07/12/2023 | Buy Now | 88.44% | Wells Fargo | Dori Kesten57% | $14.5 → $15 | Maintains | Equal-Weight | Get Alert |
07/10/2023 | Buy Now | 101.01% | Truist Securities | Patrick Scholes64% | → $16 | Reiterates | Hold → Hold | Get Alert |
07/05/2023 | Buy Now | 1470.35% | Barclays | Anthony Powell52% | $135 → $125 | Maintains | Equal-Weight | Get Alert |
06/27/2023 | Buy Now | 50.75% | Morgan Stanley | Stephen Grambling61% | $13 → $12 | Maintains | Underweight | Get Alert |
06/26/2023 | Buy Now | 75.88% | Baird | Michael Bellisario56% | $15 → $14 | Maintains | Neutral | Get Alert |
05/04/2023 | Buy Now | 82.16% | Wells Fargo | Dori Kesten57% | $14 → $14.5 | Maintains | Equal-Weight | Get Alert |
05/01/2023 | Buy Now | 63.32% | Morgan Stanley | Stephen Grambling61% | $12 → $13 | Maintains | Underweight | Get Alert |
04/27/2023 | Buy Now | 94.72% | Stifel | Simon Yarmak54% | $15.25 → $15.5 | Maintains | Hold | Get Alert |
04/26/2023 | Buy Now | 101.01% | Barclays | Anthony Powell52% | $18 → $16 | Maintains | Equal-Weight | Get Alert |
04/13/2023 | Buy Now | 101.01% | Truist Securities | Patrick Scholes64% | $18 → $16 | Maintains | Hold | Get Alert |
03/30/2023 | Buy Now | 75.88% | Wells Fargo | Dori Kesten57% | $17 → $14 | Maintains | Equal-Weight | Get Alert |
03/27/2023 | Buy Now | 91.58% | Stifel | Simon Yarmak54% | $16.5 → $15.25 | Maintains | Hold | Get Alert |
02/07/2023 | Buy Now | 50.75% | Morgan Stanley | Stephen Grambling61% | $13 → $12 | Maintains | Underweight | Get Alert |
02/02/2023 | Buy Now | 113.57% | Wells Fargo | Dori Kesten57% | $18 → $17 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | 107.29% | Citigroup | Smedes Rose38% | $15 → $16.5 | Maintains | Neutral | Get Alert |
01/18/2023 | Buy Now | 63.32% | Morgan Stanley | Stephen Grambling61% | $15 → $13 | Maintains | Underweight | Get Alert |
12/21/2022 | Buy Now | 126.13% | Barclays | Anthony Powell52% | $22 → $18 | Maintains | Equal-Weight | Get Alert |
12/09/2022 | Buy Now | — | Raymond James | William Crow70% | — | Downgrade | Outperform → Market Perform | Get Alert |
12/05/2022 | Buy Now | 88.44% | Morgan Stanley | Stephen Grambling61% | → $15 | Initiates | → Underweight | Get Alert |
12/02/2022 | Buy Now | 126.13% | BMO Capital | Ari Klein43% | $20 → $18 | Downgrade | Outperform → Market Perform | Get Alert |
11/01/2022 | Buy Now | 176.38% | Raymond James | William Crow70% | $24 → $22 | Maintains | Outperform | Get Alert |
10/31/2022 | Buy Now | 251.76% | Compass Point | Floris Van Dijkum58% | $33 → $28 | Maintains | Buy | Get Alert |
10/31/2022 | Buy Now | 163.82% | Baird | Michael Bellisario56% | $23 → $21 | Maintains | Neutral | Get Alert |
10/20/2022 | Buy Now | 126.13% | Truist Securities | Patrick Scholes64% | $24 → $18 | Maintains | Hold | Get Alert |
08/29/2022 | Buy Now | 151.26% | Wells Fargo | Dori Kesten57% | → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/07/2022 | Buy Now | 176.38% | Barclays | Anthony Powell52% | $26 → $22 | Maintains | Equal-Weight | Get Alert |
The latest price target for Pebblebrook Hotel (NYSE:PEB) was reported by Compass Point on March 10, 2025. The analyst firm set a price target for $0.00 expecting PEB to fall to within 12 months (a possible -100.00% downside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Pebblebrook Hotel (NYSE:PEB) was provided by Compass Point, and Pebblebrook Hotel downgraded their neutral rating.
The last upgrade for Pebblebrook Hotel Trust happened on November 22, 2024 when Stifel raised their price target to $15. Stifel previously had a hold for Pebblebrook Hotel Trust.
The last downgrade for Pebblebrook Hotel Trust happened on March 10, 2025 when Compass Point changed their price target from N/A to N/A for Pebblebrook Hotel Trust.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pebblebrook Hotel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pebblebrook Hotel was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
While ratings are subjective and will change, the latest Pebblebrook Hotel (PEB) rating was a downgraded with a price target of $0.00 to $0.00. The current price Pebblebrook Hotel (PEB) is trading at is $7.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.